{"id":"W4361954460","doi":"10.1158/1078-0432.c.6533189.v1","title":"Data from Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer","year":2023,"lang":"en","type":"preprint","venue":"","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"F. Hoffmann-La Roche","keywords":"Trastuzumab; Breast cancer; Oncology; Biomarker; Medicine; Internal medicine; Adjuvant; Cancer; Biology; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"dataset","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"dataset","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004733908,0.0004764611,0.001501825,0.0003103485,0.000269871,0.0009044171,0.0006524523,0.0006643583,0.001835653],"category_scores_gemma":[0.005313178,0.0003217839,0.001486174,0.0008190337,0.0002523604,0.0006046831,0.0004860628,0.0009250239,0.0004360774],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005801376,"about_ca_system_score_gemma":0.0007573774,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001752339,"about_ca_topic_score_gemma":0.004514957,"domain_scores_codex":[0.9974532,0.001494362,0.0002255151,0.0003037058,0.0003984204,0.0001247102],"domain_scores_gemma":[0.9952381,0.00194098,0.001311653,0.0006541117,0.0003513618,0.0005036581],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5497224,0.002602485,0.3098188,0.002478601,0.03539434,0.0002906395,0.0003618633,0.003837797,0.01039964,0.0004179768,0.02214306,0.06253243],"study_design_scores_gemma":[0.0755187,0.03000619,0.8490764,0.0002277748,0.01583411,0.0004719716,0.000153299,0.001437211,0.004299332,0.00034036,0.02253471,0.00009976571],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.9623985,0.00494024,0.0006975887,0.0005163444,0.00008782506,0.0004133397,0.02838423,0.00003426801,0.002527653],"genre_scores_gemma":[0.9514693,0.001123274,0.0007316372,0.0007840478,0.00006334996,0.0007755152,0.04304044,0.00003308598,0.001979298],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.004733908,"threshold_uncertainty_score":0.02503556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3330609675641214,"score_gpt":0.485229057227324,"score_spread":0.1521680896632026,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}